Suministro de Everolimus (DOE), Riluzol (DOE), Alfa 1 antitripsina (DOE), Trióxido arsénico (DOE), Inhibidor de C1 derivado del plasma (DOE) y complejo protombina humana en sus distintas composiciones
TED · 658132-2026Award notice · modificationawardedNo deadline given
Buyer
NameOSAKIDETZA - Servicio Vasco de Salud - Organización Central
CountryES
Published2026-09-24
Deadline—
Value
Estimated—
Awarded€3,175,070 · 3,175,070 EUR
WinnerALTAN PHARMACEUTICALS, S.A. | CSL BEHRING, S.A. | GRIFOLS MOVACO, S.A. | LABORATORIO STADA, S.L. | TEVA PHARMA, S.L. | TAKEDA FARMACÉUTICA ESPAÑA, S.A. | OCTAPHARMA, S.A.
Who already wins at this buyer
Firms with recorded awards from OSAKIDETZA - Servicio Vasco de Salud - Organización Central in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| PFIZER, S.L. | 6 | €70,248,230 | 2026-10-28 |
| ASTRAZENECA FARMACEUTICA SPAIN, S.A. | 6 | €14,614,191 | 2026-10-22 |
| EDWARDS LIFESCIENCIES, S.L. | ABBOTT MEDICAL ESPAÑA SA | MEDTRONIC IBÉRICA, S.A. | BOSTON SCIENTIFIC IBÉRICA, S.A. | MERCÉ V. ELECTROMEDICINA, S.L. | PALEX MEDICAL | SAGITTAE MEDICAL S.L | SERMEBI 97 SL | 5 | €40,141,054 | 2026-09-18 |
| TAKEDA FARMACÉUTICA ESPAÑA, S.A. | 5 | €10,796,370 | 2026-10-16 |
| ROCHE FARMA, S.A. UNIPERSONAL | 4 | €130,837,823 | 2026-09-08 |
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Suministro de Everolimus (DOE), Riluzol (DOE), Alfa 1 antitripsina (DOE), Trióxido arsénico (DOE), Inhibidor de C1 derivado del plasma (DOE) y complejo protombina humana en sus distintas composiciones
Similar tenders
Closest by meaning — across languages, via embeddings.